These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 25418602

  • 1. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
    Reinau D, Surber C, Jick SS, Meier CR.
    Int J Cancer; 2015 Jul 01; 137(1):144-53. PubMed ID: 25418602
    [Abstract] [Full Text] [Related]

  • 2. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.
    Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, Sørensen HT.
    Cancer; 2012 Oct 01; 118(19):4768-76. PubMed ID: 22644960
    [Abstract] [Full Text] [Related]

  • 3. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer.
    Grau MV, Baron JA, Langholz B, Karagas M, Greenberg ER, Stukel TA, Mandel JS.
    Int J Cancer; 2006 Aug 01; 119(3):682-6. PubMed ID: 16496410
    [Abstract] [Full Text] [Related]

  • 4. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
    Pandeya N, Olsen CM, Thompson BS, Dusingize JC, Neale RE, Green AC, Whiteman DC, QSkin Study.
    Br J Dermatol; 2019 Oct 01; 181(4):749-760. PubMed ID: 30920641
    [Abstract] [Full Text] [Related]

  • 5. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.
    Clouser MC, Roe DJ, Foote JA, Harris RB.
    Pharmacoepidemiol Drug Saf; 2009 Apr 01; 18(4):276-83. PubMed ID: 19226541
    [Abstract] [Full Text] [Related]

  • 6. Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study.
    Torti DC, Christensen BC, Storm CA, Fortuny J, Perry AE, Zens MS, Stukel T, Spencer SK, Nelson HH, Karagas MR.
    J Am Acad Dermatol; 2011 Aug 01; 65(2):304-312. PubMed ID: 21529996
    [Abstract] [Full Text] [Related]

  • 7. Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis.
    Muranushi C, Olsen CM, Green AC, Pandeya N.
    J Am Acad Dermatol; 2016 Jan 01; 74(1):108-119.e1. PubMed ID: 26433247
    [Abstract] [Full Text] [Related]

  • 8. Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study.
    Jeter JM, Han J, Martinez ME, Alberts DS, Qureshi AA, Feskanich D.
    Cancer Causes Control; 2012 Sep 01; 23(9):1451-61. PubMed ID: 22763500
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.
    Cancer Epidemiol Biomarkers Prev; 1998 Feb 01; 7(2):157-61. PubMed ID: 9488591
    [Abstract] [Full Text] [Related]

  • 11. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma.
    Asgari MM, Chren MM, Warton EM, Friedman GD, White E.
    Arch Dermatol; 2010 Apr 01; 146(4):388-95. PubMed ID: 20157019
    [Abstract] [Full Text] [Related]

  • 12. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
    Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH.
    Arch Dermatol; 2000 Feb 01; 136(2):179-84. PubMed ID: 10677093
    [Abstract] [Full Text] [Related]

  • 13. Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis.
    Becker C, Wilson JC, Jick SS, Meier CR.
    Int J Cancer; 2015 Nov 15; 137(10):2424-31. PubMed ID: 25974157
    [Abstract] [Full Text] [Related]

  • 14. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA, VATTC Trial.
    J Natl Cancer Inst; 2008 Sep 03; 100(17):1223-32. PubMed ID: 18728281
    [Abstract] [Full Text] [Related]

  • 15. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW, Weinstock MA, Feldman SR, Coldiron BM.
    JAMA Dermatol; 2015 Oct 03; 151(10):1081-6. PubMed ID: 25928283
    [Abstract] [Full Text] [Related]

  • 16. No chemopreventive effect of nonsteroidal anti-inflammatory drugs on nonmelanoma skin cancer: evidence from meta-analysis.
    Zhang B, Liang X, Ye L, Wang Y.
    PLoS One; 2014 Oct 03; 9(5):e96887. PubMed ID: 24828489
    [Abstract] [Full Text] [Related]

  • 17. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
    Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.
    J Natl Cancer Inst; 2005 Jun 01; 97(11):805-12. PubMed ID: 15928301
    [Abstract] [Full Text] [Related]

  • 18. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF, Blot WJ.
    Cancer Epidemiol Biomarkers Prev; 1998 Feb 01; 7(2):97-102. PubMed ID: 9488582
    [Abstract] [Full Text] [Related]

  • 19. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
    Marcil I, Stern RS.
    Arch Dermatol; 2000 Dec 01; 136(12):1524-30. PubMed ID: 11115165
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.